healthcare-economics-llc.com

healthcare-economics-llc.com - Home

Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA Amgen to Begin Launching Biosimilar Adalimumab in Europe in 2018. Pfizer Provides Update on Proposed Epoetin Alfa Biosimilar. FDA approves Inflectra, a biosimilar to Remicade. Recommended for Approval in the European Union. The First Fusion Protein Biosimilar. Approved by the European Commission. FDA APPROVES FIRST BIOSIMILAR ZARXIO (FILGRASTIM-SNDZ) FROM SANDOZ. FDA accepts Sandoz’s BLA application for filgrastim biosimilar.

http://www.healthcare-economics-llc.com/

OVERVIEW OF healthcare-economics-llc.com

TRAFFIC RANK

>1,000,000

REVIEWS

0

PAGES IN THIS WEBSITE

2

LINKS TO THIS WEBSITE

CONTACTS

ADDRESSES

SOCIAL LINKS

ONLINE SINCE

WEBSITE DETAILS

SEO

PAGES

SIMILAR SITES

TRAFFIC RANK FOR HEALTHCARE-ECONOMICS-LLC.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

December

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

Sign up

CUSTOMER REVIEWS

Average Rating: 4.0 out of 5 with 12 reviews

5 star

3

4 star

6

3 star

3

2 star

0

1 star

0

Hey there! Start your review of healthcare-economics-llc.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

LOAD TIME

1.1 seconds

FAVICON PREVIEW

16x16
32x32
64x64
128x128

CONTACTS AT HEALTHCARE-ECONOMICS-LLC.COM

HEALTHCARE ECONOMICS LLC

JAMES HARRIS

202 2ND●●●●●●●TH #445

ST P●●●●BURG , FL, 33701

UNITED STATES

1727●●●●1392

JR●●●@TAMPABAY.RR.COM

View this contact

HEALTHCARE ECONOMICS LLC

JAMES HARRIS

202 2ND●●●●●●●TH #445

ST P●●●●BURG , FL, 33701

UNITED STATES

1727●●●●1392

JR●●●@TAMPABAY.RR.COM

View this contact

VALUEWEB

DOMAIN TECH

3250 W. ●●●●●●●●AL BLVD.

FT. L●●●●●RDALE , FL, 33309

UNITED STATES

1954●●●●8000

DO●●●●●●●●@VALUEWEB.NET

View this contact

ADD CONTACT

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

DOMAIN REGISTRATION INFORMATION

REGISTERED: 2008 January 17
UPDATED: 2014 January 15
EXPIRATION: EXPIRED REGISTER THIS DOMAIN

BUY YOUR DOMAIN

DOMAIN AGE

16

YEARS
3

MONTHS
24

DAYS

NAME SERVERS

1: a.dns.hostway.net
2: b.dns.hostway.net

REGISTRAR

DOMAINPEOPLE, INC.

WHOIS : whois.domainpeople.com

REFERRED : http://www.domainpeople.com

CONTENT

PAGES IN
THIS WEBSITE

2

SSL

EXTERNAL LINKS

19

SITE IP

64.71.33.148

LOAD TIME

1.11 sec

SCORE

6.2

PAGE TITLE

healthcare-economics-llc.com - Home | healthcare-economics-llc.com Reviews

<META> DESCRIPTION

Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA Amgen to Begin Launching Biosimilar Adalimumab in Europe in 2018. Pfizer Provides Update on Proposed Epoetin Alfa Biosimilar. FDA approves Inflectra, a biosimilar to Remicade. Recommended for Approval in the European Union. The First Fusion Protein Biosimilar. Approved by the European Commission. FDA APPROVES FIRST BIOSIMILAR ZARXIO (FILGRASTIM-SNDZ) FROM SANDOZ. FDA accepts Sandoz’s BLA application for filgrastim biosimilar.

<META> KEYWORDS

1 samsung bioepis’ flixabi

2 infliximab biosimilar

3 samsung bioepis’ benepali

4 biosimilars conference

5 boston usa

6 industry expertise

7 core competencies

8 services

9 about us

10 business model

CONTENT

Page content here

KEYWORDS ON PAGE

samsung bioepis’ flixabi,infliximab biosimilar,samsung bioepis’ benepali,biosimilars conference,boston usa,industry expertise,core competencies,services,about us,business model,team,news/events,biotechnology,pharmaceuticals,strategic alliances,industries

SERVER

Apache

CONTENT-TYPE

utf-8

GOOGLE PREVIEW

healthcare-economics-llc.com - Home | healthcare-economics-llc.com Reviews

https://healthcare-economics-llc.com

Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA Amgen to Begin Launching Biosimilar Adalimumab in Europe in 2018. Pfizer Provides Update on Proposed Epoetin Alfa Biosimilar. FDA approves Inflectra, a biosimilar to Remicade. Recommended for Approval in the European Union. The First Fusion Protein Biosimilar. Approved by the European Commission. FDA APPROVES FIRST BIOSIMILAR ZARXIO (FILGRASTIM-SNDZ) FROM SANDOZ. FDA accepts Sandoz’s BLA application for filgrastim biosimilar.

INTERNAL PAGES

healthcare-economics-llc.com

1

healthcare-economics-llc.com - Home

http://www.healthcare-economics-llc.com/index.php

FDA approves Inflectra, a biosimilar to Remicade. Recommended for Approval in the European Union. The First Fusion Protein Biosimilar. Approved by the European Commission. FDA APPROVES FIRST BIOSIMILAR ZARXIO (FILGRASTIM-SNDZ) FROM SANDOZ. Hospira launches first biosimilar monoclonal antibody (mAb) Inflectra (infliximab) in major European markets. FDA Approves Teva’s GRANIX (tbo-filgrastim) Injection for Self-Administration. FDA accepts Sandoz’s BLA application for filgrastim biosimilar. August 30, 2012.

2

healthcare-economics-llc.com - About Us

http://www.healthcare-economics-llc.com/index.php?page=about-us

FDA approves Inflectra, a biosimilar to Remicade. Recommended for Approval in the European Union. The First Fusion Protein Biosimilar. Approved by the European Commission. FDA APPROVES FIRST BIOSIMILAR ZARXIO (FILGRASTIM-SNDZ) FROM SANDOZ. Hospira launches first biosimilar monoclonal antibody (mAb) Inflectra (infliximab) in major European markets. FDA Approves Teva’s GRANIX (tbo-filgrastim) Injection for Self-Administration. FDA accepts Sandoz’s BLA application for filgrastim biosimilar. August 30, 2012.

UPGRADE TO PREMIUM TO VIEW 0 MORE

TOTAL PAGES IN THIS WEBSITE

2

LINKS TO THIS WEBSITE

biosimilarnews.com

World’s first biosimilar antibody* is approved in Korea

http://www.biosimilarnews.com/worlds-first-biosimilar-antibody-is-approved-in-korea

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. Sign up for our newsletter. A biobetter trastuzumab is on the way. EGA president calls on Member States to boost market access for biosimilars in the EU. 3rd Forum on Biosimilars. Pfizer starts biosimilar rituximab Phase I/II trial. World’s first biosimilar antibody* is approved in Korea. A biosimilar manufacturer: Celltrion. You are here: Home. As Kor...

biosimilarnews.com

News/Headlines — Biosimilar News

http://www.biosimilarnews.com/category/news

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Archive for Category: "News/Headlines". Coherus BioSciences announces positive Phase III results for CHS-1420 (Humira biosimilar candidate) in psoriasis patients. Coherus BioSciences, Inc., reported topline results from an ongoing Phase 3 clinical study of CHS-1420, an adalimumab (Humira) biosimilar candidate. Read full story →. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. 3rd Forum on Biosimilars.

biosimilarnews.com

Policies — Biosimilar News

http://www.biosimilarnews.com/category/policies

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Archive for Category: "Policies". 70 stakeholder groups call on the FDA, urging distinguishable, meaningful suffixes for biosimilars. In a letter to the FDA this week, a 70-group coalition of healthcare stakeholders including patient and provider organizations and others urged the use of distinguishable, meaningful suffixes for biosimilars. Read full story →. Contact us via E-Mail. Follow us on Twitter. GMiA becomes Ge...

biosimilarnews.com

Past Events — Biosimilar News

http://www.biosimilarnews.com/category/events/past-events

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Archive for Category: "Past Events". Manufacturing of Biologics and Biosimilars. Fleming Events is organizing the Manufacturing of Biologics and Biosimilars Conference in Munich, Germany on 14-15 April 2016. Read full story →. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. Sign up for our newsletter. A biobetter trastuzumab is on the way. 3rd Forum on Biosimilars. February 8, 2016 9:05 AM. On India...

biosimilarnews.com

A biobetter trastuzumab is on the way

http://www.biosimilarnews.com/a-biobetter-trastuzumab-is-on-the-way

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. Sign up for our newsletter. A biobetter trastuzumab is on the way. EGA president calls on Member States to boost market access for biosimilars in the EU. 3rd Forum on Biosimilars. Pfizer starts biosimilar rituximab Phase I/II trial. World’s first biosimilar antibody* is approved in Korea. A biosimilar manufacturer: Celltrion. You are here: Home. Biolog...

biosimilarnews.com

Upcoming Events — Biosimilar News

http://www.biosimilarnews.com/category/events/upcoming-events

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Archive for Category: "Upcoming Events". SMi Group is thrilled to present the 7th annual conference, Biosimilars Europe, taking place on 29th and 30th September 2016 in Central London, UK. Read full story →. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. Sign up for our newsletter. A biobetter trastuzumab is on the way. 3rd Forum on Biosimilars. Pfizer starts biosimilar rituximab Phase I/II trial.

biosimilarnews.com

EGA president calls on Member States to boost market access for biosimilars in the EU

http://www.biosimilarnews.com/ega-president-calls-on-member-states-to-boost-market-access-for-biosimilars-in-the-eu

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. Sign up for our newsletter. A biobetter trastuzumab is on the way. EGA president calls on Member States to boost market access for biosimilars in the EU. 3rd Forum on Biosimilars. Pfizer starts biosimilar rituximab Phase I/II trial. World’s first biosimilar antibody* is approved in Korea. A biosimilar manufacturer: Celltrion. You are here: Home. An EU/...

biosimilarnews.com

A biosimilar manufacturer: Celltrion

http://www.biosimilarnews.com/a-biosimilar-manufacturer-celltrion

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. Sign up for our newsletter. A biobetter trastuzumab is on the way. EGA president calls on Member States to boost market access for biosimilars in the EU. 3rd Forum on Biosimilars. Pfizer starts biosimilar rituximab Phase I/II trial. World’s first biosimilar antibody* is approved in Korea. A biosimilar manufacturer: Celltrion. You are here: Home. Korean...

biosimilarnews.com

adalimumab — Biosimilar News

http://www.biosimilarnews.com/tags/adalimumab

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. Sign up for our newsletter. A biobetter trastuzumab is on the way. EGA president calls on Member States to boost market access for biosimilars in the EU. 3rd Forum on Biosimilars. Pfizer starts biosimilar rituximab Phase I/II trial. World’s first biosimilar antibody* is approved in Korea. A biosimilar manufacturer: Celltrion. August 9, 2016 11:48 AM.

biosimilarnews.com

Copyright

http://www.biosimilarnews.com/copyright

In order not to miss any updates, follow us on Twitter. Or sign up for our Newsletter. Contact us via E-Mail. Follow us on Twitter. Follow us on LinkedIn. Sign up for our newsletter. A biobetter trastuzumab is on the way. EGA president calls on Member States to boost market access for biosimilars in the EU. 3rd Forum on Biosimilars. Pfizer starts biosimilar rituximab Phase I/II trial. World’s first biosimilar antibody* is approved in Korea. A biosimilar manufacturer: Celltrion. New Corporate Laws Treatise.

UPGRADE TO PREMIUM TO VIEW 9 MORE

TOTAL LINKS TO THIS WEBSITE

19

OTHER SITES

healthcare-dramir.blogspot.com

HEALTH CARE

healthcare-dream.com

FORT MYERS REAL ESTATE - Real Estate Fort Myers

Real estate for sale in fort Myers. Homes to buy and sell with the best real estate service agent in florida. FORT MYERS REAL ESTATE. Real Estate Fort Myers. Find your MLS listing click here. Contact me at (239)324 0224 so I can personally assist in finding your dream home or business. Buy Sell Home or Business.

healthcare-e.org

HEALTHCARE DIRECTORY: Add Your Hospitals, Doctors, or Healthcare Services

A Directory Resource for Hospitals, Doctors, Clinics and General Healthcare Providers. Find all the products and services you need to effectively manage the delivery of healthcare services to the public. Health Care Billing Software. Hospitals and Medical Centers. Hospitals and Medical Centers Directory. Personal Health Record Online. Ad-agency level graphic skills combined with the web savvy you'd expect from leading online marketing firm SEO Advantage.

healthcare-eat.com

大人数の式を挙げる結婚式場

healthcare-econocom.nl

Econocom Healthcare

Skip to main content. Econocom Healthcare - home. Hoe gaan wij te werk. Gespecialiseerd in financieringsoplossingen voor de zorgsector. Econocom Healthcare kent de markt, branches en doelgroepen. Maatwerkoplossingen die zijn afgestemd op bedrijfsbehoefte en -doelstellingen. Leasen is slimmer investeren dan kopen! Wednesday, June 17, 2015 - 16:47. Bekijk nu de virtuele operatiekamer. Friday, April 24, 2015 - 16:42. Anderen over Econocom Healthcare. Master IT by Econocom, de IT asset management tool! Wij w...

healthcare-economics-llc.com

healthcare-economics-llc.com - Home

Amgen And AbbVie Agree To Settlement Allowing Commercialization Of AMGEVITA Amgen to Begin Launching Biosimilar Adalimumab in Europe in 2018. Pfizer Provides Update on Proposed Epoetin Alfa Biosimilar. FDA approves Inflectra, a biosimilar to Remicade. Recommended for Approval in the European Union. The First Fusion Protein Biosimilar. Approved by the European Commission. FDA APPROVES FIRST BIOSIMILAR ZARXIO (FILGRASTIM-SNDZ) FROM SANDOZ. FDA accepts Sandoz’s BLA application for filgrastim biosimilar.

healthcare-economics.org

National Institute for Pharmaco-Economics & Healthcare Policy: Dr. David Gershon, MD, JD, MPH Dr. Dave Gershon MD JD MPH

Governments around the world are beginning a long term process that reviews and redesigns its healthcare systems addressing concerns of cost, equitable access, and sustained quality of healthcare. In this environment the challenge before us is clear. To effectively solve systemic healthcare problems we must come together and "break through boundaries within government sectors, between government and non-governmental organizations and between the public and private sector". News, Updates, and Seminars.

healthcare-economist.com

Healthcare Economist

Unbiased Analysis of Today's Healthcare Issues. Written By: Jason Shafrin. Mar• 28•18. For choosing cancer treatments. What we know about diet:. Posted in Current Events. Long-Term Health and Economic Value of Improved Mobility among Older Adults in the U.S. Written By: Jason Shafrin. Mar• 27•18. This is the title of a recent paper by myself and co-authors Mina Kabiri, Michelle Brauer, Jeff Sullivan, Thomas M. Gill, and Dana P. Goldman published in Value in Health. In the third step, we estimated their b...

healthcare-ecosystem.com

Healthcare Ecosystem | My mission is to study and determine how healthcare policies and ethics shape the future of healthcare delivery in our society.

My mission is to study and determine how healthcare policies and ethics shape the future of healthcare delivery in our society. Follow Healthcare Ecosystem on WordPress.com. A father, and a student with a love for healthcare. Goran's layout adjusts itself depending on the device you are using. This means your site will look good not only on laptop browsers, but also on devices with smaller screens, such as the iPad and the iPhone. This area of your home page is configured by going to the Customizer.

healthcare-ecpd.co.za

eCPD Healthcare

Skip to main content. By field of practice. No Unauthorised Duplication Allowed. You are not logged in. ( Login. The following images are courtesy at FreeDigitalPhotos.net: "Businessman With Pointing Forward" of stockimages, "Happy Girl Doing On Line Shopping" of marin, "Man Sitting With Laptop" by photostock. Powered by AOSIS Ituta.

healthcare-ed.com

Contact - Healthcare Education Services Healthcare Education Services

Register here. We will let you know about forthcoming programmes. Oncology Courses. Therapy Area Training for Pharmaceutical Industry. Healthcare Education Services will be suspending its operations shortly. The staff and Directors would like to take this opportunity to thank our many clients and suppliers for their support over the last three decades and to convey our wishes for every success in the future. A well organised programme. I will recommend to colleagues. Asthma and COPD: An Overview.